Verilumia 
FDA approves Hibsago for some adults with hepatitis B
The U.S. Food and Drug Administration approved Hibsago, a new treatment for certain adults with chronic hepatitis B, on October 20, offering some patients a chance to stop taking their existing antiviral medicine...
